Lv3
230 积分 2026-07-07 加入
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
2个月前
已完结
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study
2个月前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
2个月前
已完结
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
2个月前
已完结
[Efficacy and clinical remission in patients with severe asthma and blood eosinophil counts ≥150 cells/μl treated with benralizumab: a sub-analysis of the Phase 3 MIRACLE study]
2个月前
已完结
Follow-up after discontinuation of omalizumab in patients with moderate-to-severe asthma: A systematic review
2个月前
已完结
Efficacy and Safety of Biologics for Oral Corticosteroid–Dependent Asthma: A Systematic Review and Network Meta-Analysis
2个月前
已完结
Comparative Effectiveness of Approved Biologics in Treating Moderate-To-Severe Allergic Asthma: A Systematic Review and Network Meta-Analysis
2个月前
已完结
Biologics in severe asthma: from precision phenotyping to clinical remission
2个月前
已完结
皖公网安备34019202002308
